Jump to content

Eleanor Barnes

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Jesswade88 (talk | contribs) at 20:37, 18 September 2021 (started page). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Eleanor (Ellie) Barnes
Alma materUniversity of Oxford
St Bartholomew's Hospital
Scientific career
InstitutionsJohn Radcliffe Hospital
University of Oxford
ThesisT-cell and dendritic cell function and the effects of combination therapy in Hepatitis C virus infection (2004)

Eleanor (Ellie) Barnes is a British physician at the John Radcliffe Hospital and a Professor of Hepatology and Experimental Medicine at the University of Oxford. She has studied Hepatitis C and the development of the development of HCV vaccines. She led international research efforts investigating IgG4 disease. She is a Fellow of the Academy of Medical Sciences.

Early life and education

Barnes has said that she was interested in science as a child.[1] She decided to study medicine at university, and eventually trained in medicine at St Bartholomew's Hospital.[1] She completed an intercalated bachelor's degree in anthropology and philosopy.[1] After graduating she worked as a medical resident at the Royal Free Hospital, where she decided to specialise in hepatology and gastroenterology. Determined to pursue a career in research, Barnes worked unpaid for several months, during which time she obtained data that she used to apply for a fellowship from the Medical Research Council. She was a doctoral researcher at the University of Oxford. Her doctoral research considered T cell and dendritic cell function.[2]

Research and career

Her research considers T cell immunology. She is focussed on the translation of laboratory findings to clinical environments. Barnes worked as a Medical Research Council Senior Fellow at the University of Oxford, and eventually was appointed lead of herpetology in the Thames Valley.[3][4] She studied why 80% of patients with Hepatitis C get chronic infection.[3] Barnes identified that the nature of the T cell response determines which pathway a patient goes down. This observation led Barnes to develop an T-cell vaccine to prevent Hepatitis C infection. The vaccine is based on adenoviral vectors, which host the non-structural proteins of Hepatitis C from a genotype 1B strain.[3] There are seven major Hepatitis C strains, which presents considerable challenges for the development of vaccines.[3] Barnes was elected Fellow of the Academy of Medical Sciences in 2018.[5]

During the COVID-19 pandemic Barnes studied the design, effectiveness and implementation of the COVID-19 vaccine.[6] She showed that patients who suffered from COVID-19 were likely to be impacted by liver problems.[7]

Select publications

Personal life

Barnes is married with two children.[3]

References

  1. ^ a b c "Eleanor Barnes — Diversity Projects". parking.haiku.fry-it.com. Retrieved 2021-09-18.
  2. ^ Barnes, Eleanor (2004). T-cell and dendritic cell function and the effects of combination therapy in Hepatitis C virus infection (Thesis).
  3. ^ a b c d e "Ellie Barnes: Women in Science - Internal Speaker — Working for NDM". www.ndm.ox.ac.uk. Retrieved 2021-09-18.
  4. ^ "PITCH Study". www.pitch-study.org. Retrieved 2021-09-18.
  5. ^ "Professor Eleanor Barnes | The Academy of Medical Sciences". acmedsci.ac.uk. Retrieved 2021-09-18.
  6. ^ "UK scientists back Covid boosters as study finds post-jab falls in antibodies". the Guardian. 2021-07-22. Retrieved 2021-09-18.
  7. ^ "Liver problems common among COVID-19 patients, study finds". NIHR Oxford Biomedical Research Centre. 2021-07-23. Retrieved 2021-09-18.